Mesoblast (MESO) Total Non-Current Liabilities (2015 - 2025)

Mesoblast (MESO) has reported Total Non-Current Liabilities for 11 consecutive years, with $79.6 million the latest figure, recorded in Q4 2025.

• Quarterly Total Non-Current Liabilities fell 33.32% year-over-year to $79.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $79.6 million (down 33.32% YoY) and the FY2025 annual result came in at $84.6 million, down 26.78% from the prior year.
• Total Non-Current Liabilities fell to $79.6 million in Q4 2025 per MESO's latest filing, from $84.6 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for MESO reached as high as $130.2 million in Q4 2023 and fell as low as $66.6 million in Q1 2021.
• A 5-year average of $102.5 million and a median of $112.9 million in 2022 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2021 — Total Non-Current Liabilities sank 34.2% — and 2022, when it soared 68.61%.
• Year by year, Total Non-Current Liabilities stood at $111.0 million in 2021, then gained by 2.26% to $113.5 million in 2022, then grew by 14.72% to $130.2 million in 2023, then decreased by 8.36% to $119.3 million in 2024, then tumbled by 33.32% to $79.6 million in 2025.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $79.6 million, $84.6 million, and $119.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.